Echo Street Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,361
Closed -$593K 143
2023
Q3
$593K Buy
1,361
+291
+27% +$132K 0.01% 227
2023
Q2
$475K Sell
1,070
-606
-36% -$280K ﹤0.01% 277
2023
Q1
$771K Buy
1,676
+921
+122% +$438K 0.01% 161
2022
Q4
$387K Buy
+755
New +$383K ﹤0.01% 355
2022
Q3
Sell
-875
Closed -$422K 594
2022
Q2
$422K Buy
+875
New +$433K ﹤0.01% 352
2022
Q1
Sell
-1,796
Closed -$833K 649
2021
Q4
$833K Buy
+1,796
New +$756K 0.01% 288
2021
Q3
Sell
-865
Closed -$330K 659
2021
Q2
$330K Buy
+865
New +$331K ﹤0.01% 468

Other funds holding ELV

Echo Street Capital Management's ELV Position: Q4 2023 in Review

Echo Street Capital Management sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 1,361 shares — an estimated $593K sold.

Echo Street Capital Management first reported a position in ELV in Q2 2021 and held it in 7 quarters. The position peaked at $833K in Q4 2021. 1,656 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Echo Street Capital Management reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Echo Street Capital Management sold 1,361 Elevance Health shares in Q4 2023, an estimated $593K.
  • Echo Street Capital Management first reported a position in Elevance Health in Q2 2021 and held it in 7 quarters.
  • Echo Street Capital Management's Elevance Health position peaked at $833K in Q4 2021.
  • 1,656 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Echo Street Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.